Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Vomiting 3Nausea 2Uterine Cervical Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

Cisplatin 15Gemcitabine 7Fluorouracil 6Docetaxel 6Radiotherapy, Intensity-Modulated 5Oxaliplatin 4Capecitabine 4pembrolizumab 3Radiotherapy 3Carboplatin 3Acupuncture Therapy 3Psychiatric Rehabilitation 2Paclitaxel 2Nicotine 2Counseling 2Cetuximab 2Celecoxib 2Bupropion 2tislelizumab 1spartalizumab 1sargramostim 1motexafin gadolinium 1fosaprepitant 1fialuridine 1endostar protein 1cc-486 1apatinib 1Zoledronic Acid 1Zinc Oxide 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Neoplasms × Tropisetron × Clear all
NCT05564286 2024-02-06

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Shantou University Medical College

Phase 3 Completed
116 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Nasopharyngeal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡